We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
–
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$27.2M
2
AMZN icon
Amazon
AMZN
+$19.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.8M
4
EAT icon
Brinker International
EAT
+$15.8M
5
APD icon
Air Products & Chemicals
APD
+$15.1M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$145M 3.57%
5,115,176
+426,844
+9% +$11.3M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.08T
$101M 2.49%
2,505,880
+920
+0% +$36K
MSFT icon
3
Microsoft
MSFT
$3.35T
$82.5M 2.04%
1,432,543
+122,523
+9% +$6.92M
META icon
4
Meta Platforms (Facebook)
META
$1.37T
$74.9M 1.85%
584,274
+3,564
+0.6% +$442K
AMZN icon
5
Amazon
AMZN
$2.53T
$65.4M 1.62%
1,561,980
+508,160
+48% +$19.4M
AMGN icon
6
Amgen
AMGN
$209B
$62.1M 1.53%
372,403
-80,850
-18% -$13.7M
UNH icon
7
UnitedHealth
UNH
$383B
$61.9M 1.53%
442,168
+2,853
+0.6% +$400K
CMCSA icon
8
Comcast
CMCSA
$84B
$54.1M 1.34%
1,630,424
+3,506
+0.2% +$117K
GILD icon
9
Gilead Sciences
GILD
$163B
$53M 1.31%
670,161
-58,941
-8% -$4.79M
XOM icon
10
ExxonMobil
XOM
$651B
$44.9M 1.11%
514,329
-1,444
-0.3% -$128K
V icon
11
Visa
V
$684B
$42.7M 1.05%
516,076
+665
+0.1% +$53.2K
BR icon
12
Broadridge
BR
$17.9B
$40M 0.99%
590,468
-90,296
-13% -$6.16M
CVS icon
13
CVS Health
CVS
$134B
$39.7M 0.98%
445,630
-533
-0.1% -$50.3K
JNJ icon
14
Johnson & Johnson
JNJ
$617B
$37.6M 0.93%
318,593
-1,148
-0.4% -$139K
ETN icon
15
Eaton
ETN
$150B
$37.6M 0.93%
572,149
+510
+0.1% +$33K
JPM icon
16
JPMorgan Chase
JPM
$933B
$37.3M 0.92%
559,633
-25,301
-4% -$1.65M
NOC icon
17
Northrop Grumman
NOC
$76B
$36.7M 0.91%
171,577
-756
-0.4% -$164K
LLL
18
DELISTED
L3 Technologies, Inc.
LLL
$35.8M 0.88%
237,304
-7,835
-3% -$1.17M
CELG
19
DELISTED
Celgene Corp
CELG
$34.2M 0.85%
327,486
+6,509
+2% +$704K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.1T
$34.2M 0.85%
236,931
+89,131
+60% +$13M
BIIB icon
21
Biogen
BIIB
$30.7B
$34M 0.84%
108,592
-18,755
-15% -$5.55M
BMY icon
22
Bristol-Myers Squibb
BMY
$132B
$33.6M 0.83%
622,617
+60,690
+11% +$3.9M
ABBV icon
23
AbbVie
ABBV
$455B
$33M 0.82%
523,354
+419,878
+406% +$27.2M
CSCO icon
24
Cisco
CSCO
$448B
$32.3M 0.8%
1,018,286
-1,190
-0.1% -$36.6K
QCOM icon
25
Qualcomm
QCOM
$159B
$29.3M 0.72%
427,249
+4,479
+1% +$272K
1
2 3 4 5

Similar funds

GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.